Table 1.
Participant demographics and baseline characteristics.
| Characteristic | All participants (N = 61) |
|---|---|
| Median age (range) | 60 (38–78) |
| Sex, n (%) | |
| Male | 31 (51) |
| Female | 30 (49) |
| Primary tumor type, n (%) | |
| Melanoma | 19 (31) |
| SCCa | 11 (18) |
| Adenocarcinomaa | 7 (12) |
| Head and neck cancer | 7 (12) |
| Breast cancer | 3 (5) |
| Lung cancer | 3 (5) |
| Colorectal carcinoma | 3 (5) |
| Pancreatic cancer | 2 (3) |
| Prostate cancer | 2 (3) |
| Chondrosarcoma | 1 (2) |
| Gastric cancer | 1 (2) |
| Mesothelioma | 1 (2) |
| Ovarian cancer | 1 (2) |
| Stage at study entry, n (%) | |
| III | 3 (5) |
| IV | 56 (92) |
| Missing | 2 (3) |
| ECOG performance status, n (%) | |
| 0 | 22 (36) |
| 1 | 39 (64) |
| Prior lines of therapy, n (%) | |
| 0 | 9 (15) |
| 1 | 15 (25) |
| 2 | 13 (21) |
| 3 | 11 (18) |
| >3 | 13 (21) |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.
a
Unknown primary origin.